retatrutide ly3437943 triple agonist glp-1 gip glucagon just had its biggest data year yet. In 2026, Eli Lilly's GLP-1/GIP/glucagon receptor posted two major Phase 3 readouts: TRIUMPH-1 (obesity, 2,339 participants) showed a 28.3% average body weight Retatrutide: A metabolic upgrade for

Source: Indian Journal of Gastroenterology

Compare Mounjaro vs Ozempic to understand their differences, benefits, and effectiveness in medical weight management.

You can now choose between GLP-1 pills or shots for weight loss

Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option

Arizona OPEN ACCESS PUBLISHED:30 October 2024 CITATION:Chakkera, S

Diabetes mellitus, a condition that significantly elevates the incidence and mortality risks associated with cardiovascular diseases, exacerbates the disease burden in China